Have a feature idea you'd love to see implemented?
Let us know!
DERM Journey Medical Corp
Price (delayed)
$5.2
Market cap
$108.63M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.94
Enterprise value
$107.24M
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated
Highlights
The company's quick ratio rose by 48% YoY
The debt is down by 8% QoQ
Journey Medical's net income has decreased by 48% YoY
The equity has declined by 37% year-on-year and by 3.3% since the previous quarter
Key stats
What are the main financial stats of DERM
Market
Valuations
Earnings
Shares outstanding
20.89M
Market cap
$108.63M
Enterprise value
$107.24M
Price to earnings (P/E)
N/A
Price to book (P/B)
9.86
Price to sales (P/S)
1.85
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.86
Revenue
$57.77M
EBIT
-$16.32M
EBITDA
-$12.97M
Free cash flow
-$27.87M
Per share
Balance sheet
Liquidity
EPS
-$0.94
Free cash flow per share
-$1.36
Book value per share
$0.53
Revenue per share
$2.81
TBVPS
$2.25
Total assets
$64.04M
Total liabilities
$53.12M
Debt
$21.07M
Equity
$10.93M
Working capital
$12.83M
Debt to equity
1.93
Current ratio
1.38
Quick ratio
0.99
Net debt/EBITDA
0.11
Margins
Efficiency
Dividend
EBITDA margin
-22.4%
Gross margin
57.3%
Net margin
-31.7%
Operating margin
-31.2%
Return on assets
-26.9%
Return on equity
-132.1%
Return on invested capital
-220.4%
Return on capital employed
-53.1%
Return on sales
-28.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
DERM stock price
How has the Journey Medical stock price performed over time
Intraday
-0.57%
1 week
2.36%
1 month
-17.72%
1 year
20.65%
YTD
-9.72%
QTD
-7.96%
Financial performance
How have Journey Medical's revenue and profit performed over time
Revenue
$57.77M
Gross profit
$33.11M
Operating income
-$18.02M
Net income
-$18.34M
Gross margin
57.3%
Net margin
-31.7%
DERM's operating margin has shrunk by 150% YoY
The net margin has shrunk by 105% YoY
Journey Medical's operating income has shrunk by 81% YoY
Journey Medical's net income has decreased by 48% YoY
Growth
What is Journey Medical's growth rate over time
Valuation
What is Journey Medical stock price valuation
P/E
N/A
P/B
9.86
P/S
1.85
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.86
DERM's EPS is down by 31% year-on-year
The equity has declined by 37% year-on-year and by 3.3% since the previous quarter
DERM's price to book (P/B) is 25% higher than its last 4 quarters average of 7.9
DERM's price to sales (P/S) is 32% higher than its last 4 quarters average of 1.4
The revenue is down by 28% year-on-year and by 26% since the previous quarter
Efficiency
How efficient is Journey Medical business performance
DERM's return on sales has dropped by 126% year-on-year
Journey Medical's return on assets has shrunk by 83% YoY
DERM's ROE is down by 12% YoY
Dividends
What is DERM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for DERM.
Financial health
How did Journey Medical financials performed over time
The company's total assets is 21% higher than its total liabilities
Journey Medical's current ratio has soared by 50% YoY
The company's quick ratio rose by 48% YoY
The debt is 93% higher than the equity
The equity has declined by 37% year-on-year and by 3.3% since the previous quarter
The debt is down by 8% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.